In this study, we observed a strong trend towards a distinctive performance of the biomarker panels among African-American patients, especially for the SteatoTest and ActiTest.
← all excerpts
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus.
1
—
—